Table 4.
Alfentanil | Midazolam | |||||
---|---|---|---|---|---|---|
Concentration (ng/ml) | ||||||
1 | 10 | 100 | 1.35 | 12 | 100 | |
Intraday run 1-mean | 0.98 | 9.67 | 102.7 | 1.36 | 10.6 | 103 |
SD | 0.04 | 0.77 | 5.6 | 0.11 | 0.5 | 7 |
%CV | 4.1 | 8.0 | 5.4 | 8.1 | 5.1 | 7.2 |
% RE | -2.0 | -3.3 | 2.7 | 0.7 | -11.3 | 2.9 |
| ||||||
Intraday run 2-mean | 0.99 | 9.88 | 97.1 | 1.39 | 12.0 | 102 |
SD | 0.05 | 0.42 | 3.2 | 0.09 | 0.6 | 6 |
%CV | 5.1 | 4.3 | 3.3 | 6.5 | 5.3 | 5.4 |
% RE | -1.0 | -1.2 | -2.9 | 3.0 | -0.2 | 2.3 |
| ||||||
Intraday run 3-mean | 0.98 | 9.83 | 97.0 | 1.32 | 12.2 | 105 |
SD | 0.05 | 0.61 | 2.8 | 0.05 | 0.7 | 4 |
%CV | 5.1 | 6.2 | 2.9 | 3.8 | 6.0 | 3.7 |
% RE | -2.0 | -1.7 | -3.0 | -2.2 | 1.8 | 4.6 |
| ||||||
Interday run-mean | 0.98 | 9.79 | 98.9 | 1.36 | 11.6 | 103 |
SD | 0.04 | 0.59 | 4.7 | 0.09 | 0.9 | 5 |
%CV | 4.1 | 6.0 | 4.7 | 6.6 | 8.0 | 5.3 |
% RE | -2.0 | -2.1 | -1.1 | 0.7 | -3.3 | 3.3 |
N | 18 | 18 | 18 | 18 | 18 | 18 |